Financial Trading Blog
Stock of the day 02/12/2014 – Abercrombie & Fitch Co
Wednesday sees Abercrombie & Fitch release its third quarter earnings in the midst of a severe sales slump. In a preliminary Q3 earnings release, the clothing company revealed a dramatic 12% drop in sales, alongside a 10% fall in like for like sales. Overall sales for the quarter fell from $1.03 billion to $911.4 billion, a drop that was well below forecasts.
CEO Mike Jeffries partly blamed these disastrous figures on a large slowdown in European sales that he said had no immediate chance of a turnaround, combined with a fall in year on year foot traffic. These issues were exacerbated by the aforementioned change in trends that led to a decline in sales of heavily logoed Abercrombie & Fitch stock, stock that makes up a large amount of the company’s overall product. This decline follows the overall damage the company suffered when comments from Jeffries, made in 2006, came to light in 2013, with the CEO stating that he didn’t want overweight or unattractive people wearing his clothes.
Unsurprisingly, share prices suffered a similar fate to the company’s sales, falling nearly 17% on November 7th, the day of the announcement, from $31.00 to $29.49, after shares had risen 4.7% the day before to $35.39. This slump was Abercrombie & Fitch’s lowest share price in a year; however prices have since fallen further to $28.12 at close on Monday.
As Abercrombie & Fitch look towards its earnings release on Wednesday, things don’t look great. Credit Suisse downgraded the company to ‘neutral’ from ‘outperform’, as well as decreasing its pricing from $53.00 to $28.00. Oppenheimer also downgraded the company from ‘outperform’, giving it a $30.00 stock target. The huge sales slump indicates the company may struggle to post any growth this quarter, despite its intention to expand into the potentially lucrative Mexican market, as it tries to battle the increasing toxicity of its brand.
It's easy to open an account
- Fill in our simple online application form
- Fund your account
- Start trading the global markets instantly!
SEARCH FOR AN ARTICLE:
Enter a keyword and search for all relevant articlesMARKET ANALYSIS
RECENT POSTS
DISCLAIMER
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.
Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.
No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.
The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.
